Resources

Best practices and models

  • HIV Community Resource

    Scientific advances will not move the world closer to achieving global health equity until everyone, everywhere can access them. This...

  • Compulsory Licensing in Eighteen Middle-Income Countries

    This study provides an analysis of provisions related to compulsory licensing (CL); it was created to assess their utility and...

  • Perspectiva comunitaria sobre la distribución de medicamentos para el VIH en Guatemala

    Estudio de Caso: Perspectiva comunitaria sobre los elementos de la cadena de abastecimiento y la distribución de medicamentos e insumos...

  • ITPC-LACTA: Compras públicas y VIH

    Este es un análisis de 41 contratos de compras de medicamentos antirretrovirales con fondos públicos en Guatemala durante el año...

  • Informe del Estado del Mercado y Patentes Honduras 2019

  • Informe del Estado del Mercado y Patentes Guatemala 2019

  • Why Ukraine needs a Patent Reform for Medicinal Products

    Ukraine’s reformed patent law came into effect in August 2020. Read the public health arguments that are relevant and can...

  • Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia) – Arabic version

  • Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia) – French version

  • Campaign toolkit – our complete guide

    Our toolkit will guide you through all the steps to challenge intellectual property barriers, from the life-cycle of a patent,...

  • Access Granted

    A budget advocacy toolkit for improving access to quality and affordable medicines through Global Fund grants.

  • The Roadmap – Special Edition Report on Tenofovir Alafenamide Fumarate (TAF)

    Make Medicines Affordable partner, the Initiative for Medicines, Access and Knowledge (I-MAK), has produced the Roadmap Special Edition Report on...